These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

127 related articles for article (PubMed ID: 16868586)

  • 1. Optimising Chlamydia testing within constrained funding.
    Morris AJ; McCarthy M
    N Z Med J; 2006 Jul; 119(1238):U2093. PubMed ID: 16868586
    [No Abstract]   [Full Text] [Related]  

  • 2. Questioning the value of screening for gonorrhoea in symptomless heterosexual men.
    Evans-Jones J
    Int J STD AIDS; 2010 Apr; 21(4):302. PubMed ID: 20378909
    [No Abstract]   [Full Text] [Related]  

  • 3. Comparison of APTIMA COMBO 2 assay with polymerase chain reaction Roche assay for detection of Chlamydia trachomatis in endocervical swabs.
    Khryanin AA; Reshetnikov OV; Vlaspolder F
    Int J STD AIDS; 2007 Dec; 18(12):871-2. PubMed ID: 18073027
    [No Abstract]   [Full Text] [Related]  

  • 4. Prospective comparison of cell cultures and nucleic acid amplification tests for laboratory diagnosis of Chlamydia trachomatis Infections.
    Jespersen DJ; Flatten KS; Jones MF; Smith TF
    J Clin Microbiol; 2005 Oct; 43(10):5324-6. PubMed ID: 16208009
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Diagnostics of chlamydia today].
    Pasternack R
    Duodecim; 1998; 114(14):1373-4. PubMed ID: 11552244
    [No Abstract]   [Full Text] [Related]  

  • 6. Diagnostic methodologies for chlamydia screening in females aged 15 to 25 years from private insurance claims data in the United States, 2001 to 2005.
    Owusu-Edusei K; Bohm MK; Kent CK
    Sex Transm Dis; 2009 Jul; 36(7):419-21. PubMed ID: 19556935
    [No Abstract]   [Full Text] [Related]  

  • 7. The highs and lows of opportunistic Chlamydia testing: uptake and detection in Waikato, New Zealand.
    Morgan J; Bell A
    Sex Transm Infect; 2009 Oct; 85(6):452-4. PubMed ID: 19398433
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Detection of Chlamydia trachomatis DNA using MagNA Pure DNA extraction and Cobas Amplicor CT/NG amplification.
    De Martino SJ; de Barbeyrac B; Piemont Y; Barthel C; Monteil H; Jaulhac B
    Clin Microbiol Infect; 2006 Jun; 12(6):576-9. PubMed ID: 16700708
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Comparison of three nucleic acid amplification tests for detection of Chlamydia trachomatis in urine specimens.
    Berger RE
    J Urol; 2005 Jun; 173(6):1989-90. PubMed ID: 15879801
    [No Abstract]   [Full Text] [Related]  

  • 10. Comparison of penile skin swab with intra-urethral swab and first void urine for polymerase chain reaction-based diagnosis of Chlamydia trachomatis urethritis in male patients.
    Pittaras TE; Papaparaskevas J; Houhoula DP; Legakis NJ; Frangouli E; Katsambas A; Tsakris A; Papadogeorgakis H
    Sex Transm Dis; 2008 Dec; 35(12):999-1001. PubMed ID: 18665017
    [No Abstract]   [Full Text] [Related]  

  • 11. First evaluation of six nucleic acid amplification tests widely used in the diagnosis of Chlamydia trachomatis in Russia.
    Shipitsyna E; Zolotoverkhaya E; Agné-Stadling I; Krysanova A; Savicheva A; Sokolovsky E; Domeika M; Unemo M
    J Eur Acad Dermatol Venereol; 2009 Mar; 23(3):268-76. PubMed ID: 19207643
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [New Chlamydia variation discovered in 2006. Quick transmission in Sweden, diagnostic techniques missed the mutation].
    Herrmann B
    Lakartidningen; 2007 Nov 21-27; 104(47):3535-6. PubMed ID: 18203586
    [No Abstract]   [Full Text] [Related]  

  • 13. A new automated method for isolation of Chlamydia trachomatis from urine eliminates inhibition and increases robustness for NAAT systems.
    Anglès d'Auriac M; Refseth UH; Espelund M; Moi H; Størvold G; Jeansson S
    J Microbiol Methods; 2007 Sep; 70(3):416-23. PubMed ID: 17610971
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The discovery of Chlamydia trachomatis.
    Taylor-Robinson D
    Sex Transm Infect; 2017 Feb; 93(1):10. PubMed ID: 28100758
    [No Abstract]   [Full Text] [Related]  

  • 15. The Chlamydia trachomatis plasmid deletion mutant--what does it mean to us?
    Schachter J
    Sex Transm Dis; 2007 May; 34(5):257. PubMed ID: 17483724
    [No Abstract]   [Full Text] [Related]  

  • 16. The chlamydia problem in New Zealand.
    Perkins N
    N Z Med J; 2004 May; 117(1194):U887. PubMed ID: 15156205
    [No Abstract]   [Full Text] [Related]  

  • 17. General practice funding to improve provision of adolescent primary sexual health care in New Zealand: results from an observational intervention.
    Morgan J; Haar J
    Sex Health; 2009 Sep; 6(3):203-7. PubMed ID: 19653956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical correlates of genital Chlamydia infection in the era of nucleic acid testing.
    Markos AR
    Int J STD AIDS; 2008 Jan; 19(1):34-6. PubMed ID: 18275644
    [TBL] [Abstract][Full Text] [Related]  

  • 19. First reported case of the Swedish new variant of Chlamydia trachomatis (nvCT) in Eastern Europe (Russia), and evaluation of Russian nucleic acid amplification tests regarding their ability to detect nvCT.
    Shipitsyna E; Hadad R; Ryzhkova O; Savicheva A; Domeika M; Unemo M
    Acta Derm Venereol; 2012 May; 92(3):330-1. PubMed ID: 22293657
    [No Abstract]   [Full Text] [Related]  

  • 20. Issues in Chlamydia trachomatis testing by nucleic acid amplification test.
    Hadgu A
    J Infect Dis; 2006 May; 193(9):1335-6; author reply 1338-9. PubMed ID: 16586375
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.